CGH
OFIX icon

Crossmark Global Holdings’s Orthofix Medical OFIX Stock Holding History

Crossmark Global Holdings’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,809
Closed -$278K – 1506
2018
Q3 		$278K Buy
4,809
+150
+3% +$8.4K 0.01% 1370
2018
Q2 		$265K Buy
4,659
+350
+8% +$19.9K 0.01% 1394
2018
Q1 		$253K Sell
4,309
-439
-9% -$24.6K 0.01% 1381
2017
Q4 		$260K Buy
+4,748
New +$246K 0.01% 1453

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Crossmark Global Holdings's OFIX Position: Q4 2018 in Review

Crossmark Global Holdings sold out of Orthofix Medical (OFIX) in Q4 2018, closing a stake of 4,809 shares — an estimated $278K sold.

Crossmark Global Holdings first reported a position in OFIX in Q4 2017 and held it in 4 quarters. The position peaked at $278K in Q3 2018. 171 funds tracked by Wall St. Rank hold OFIX as of Q4 2018.

  • Crossmark Global Holdings reported no remaining Orthofix Medical position as of Q4 2018 after selling out during the quarter.
  • Crossmark Global Holdings sold 4,809 Orthofix Medical shares in Q4 2018, an estimated $278K.
  • Crossmark Global Holdings first reported a position in Orthofix Medical in Q4 2017 and held it in 4 quarters.
  • Crossmark Global Holdings's Orthofix Medical position peaked at $278K in Q3 2018.
  • 171 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2018.

Based on Crossmark Global Holdings's 13F filing for Q4 2018, filed 31 Jan 2019.